Quebec SEAO #20183030

Real-time nucleic-acid sequencing system with technical support

Santé Québec’s CHU de Québec – Université Laval is seeking a real-time sequencing system for nucleic-acid research and testing. - Buyer: Santé Québec – CHU de Québec – Université Laval. - Named supplier and OEM: Oxford Nanopore Technologies Canada Limited; the notice identifies its PromethION P2 Integrated as the only benchtop system found to meet the scientific requirements. - Products and services: One PromethION P2 Integrated instrument (quantity and part number not stated), compatible commercial library-preparation kits (quantity and part number not stated), and comprehensive technical support for workflows during business days. - Key system requirements: Sequence fragments from 50 to over 100,000 nucleotides, with 50–100 billion nucleotides per flow cell; operate two independent sequencing cells with reusable flow cells; support real-time base calling and adaptive sampling using onboard computing; detect specified DNA modifications natively and directly sequence native full-length RNA; and multiplex at least 96 samples per cell. - Other notable requirements: More than 10 TB of internal storage, compact dimensions, CSA standards approval, operation from a standard 110–120 V outlet, and resistance to the organization’s specified accelerated-hydrogen-peroxide and chlorine disinfection protocols. - Procurement context: The notice reports that a previous public tender received no bids and that no alternative system meeting the requirements was identified. A qualified, admissible expression of interest could prompt a public tender instead of direct negotiations. - Estimated value: No value is stated; the range below is an approximate planning estimate.

Description

Santé Québec - CHU de Québec - Université Laval intends to enter into a negotiated contract for a real-time nucleic-acid sequencing instrument. The required system supports long-read sequencing, real-time data generation and interpretation, adaptive sampling, and native detection of DNA chemical modifications, with applications in infectious-disease diagnostics, antimicrobial-resistance surveillance, and clinical metagenomics. The notice identifies the PromethION P2 Integrated as the only benchtop instrument found to meet the stated scientific requirements. The contract duration is 48 months, with a 24-month renewal option.

View original listing